B. Riley Wealth Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9K | Buy |
+12,490
| New | +$25.9K | ﹤0.01% | 947 |
|
|
2024
Q4 | $19.3K | Hold |
12,602
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q3 | $26.1K | Buy |
12,602
+1,000
| +9% | +$2.07K | ﹤0.01% | 1248 |
|
|
2024
Q2 | $40.6K | Buy |
+11,602
| New | +$40.6K | ﹤0.01% | 1351 |
|
|
2024
Q1 | – | Sell |
-11,490
| Closed | -$19.5K | – | 1480 |
|
|
2023
Q4 | $19.5K | Buy |
+11,490
| New | +$19.5K | ﹤0.01% | 1372 |
|
|
2019
Q2 | – | Sell |
-30,686
| Closed | -$750K | – | 807 |
|
|
2019
Q1 | $750K | Buy |
30,686
+150
| +0.5% | +$3.67K | 0.09% | 237 |
|
|
2018
Q4 | $793K | Sell |
30,536
-6,116
| -17% | -$159K | 0.11% | 192 |
|
|
2018
Q3 | $1.16M | Buy |
36,652
+6,266
| +21% | +$198K | 0.14% | 166 |
|
|
2018
Q2 | $1.18M | Sell |
30,386
-10,300
| -25% | -$400K | 0.16% | 156 |
|
|
2018
Q1 | $1.12M | Sell |
40,686
-51,200
| -56% | -$1.41M | 0.16% | 153 |
|
|
2017
Q4 | $1.66M | Buy |
91,886
+23,310
| +34% | +$422K | 0.22% | 120 |
|
|
2017
Q3 | $1.11M | Buy |
68,576
+21,700
| +46% | +$351K | 0.18% | 134 |
|
|
2017
Q2 | $650K | Buy |
+46,876
| New | +$650K | 0.12% | 208 |
|
|
2015
Q1 | – | Sell |
-1,077
| Closed | -$11 | – | 1195 |
|
|
2014
Q4 | $11 | Buy |
+1,077
| New | +$11 | ﹤0.01% | 2810 |
|
|
2014
Q3 | – | Sell |
-1,077
| Closed | -$13.3K | – | 1196 |
|
|
2014
Q2 | $13.3K | Buy |
+1,077
| New | +$13.3K | ﹤0.01% | 1657 |
|